Wanbury
Wanbury Performance
Day Range
- Low 117.45
- High 117.45
52 Week Range
- Low 33.30
- High 117.45
- Open Price0.00
- Previous Close115.15
- Volume3953
Start SIP in Wanbury
Start SIPWanbury Investment Rating
-
Master Rating:
-
Wanbury has an operating revenue of Rs. 549.50 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of -2% needs improvement, The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 30% and 96% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 68 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 144 | 146 | 133 | 126 | 124 | 117 | 134 |
| Operating Expenses Qtr Cr | 127 | 133 | 119 | 119 | 118 | 120 | 122 |
| Operating Profit Qtr Cr | 17 | 13 | 14 | 6 | 6 | -3 | 13 |
| Depreciation Qtr Cr | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest Qtr Cr | 8 | 6 | 8 | 7 | 4 | 3 | 5 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | -1 |
| Net Profit Qtr Cr | 7 | 5 | 1 | -3 | -1 | -7 | 83 |
Wanbury Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹100.68
- 50 Day
- ₹89.29
- 100 Day
- ₹77.52
- 200 Day
- ₹67.52
- 20 Day
- ₹98.02
- 50 Day
- ₹88.43
- 100 Day
- ₹71.49
- 200 Day
- ₹58.47
Wanbury Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 115.15 |
| Second Resistance | 115.15 |
| Third Resistance | 115.15 |
| RSI | 89.10 |
| MFI | 89.94 |
| MACD Single Line | 5.62 |
| MACD | 7.06 |
| Support | |
|---|---|
| First Resistance | 115.15 |
| Second Resistance | 115.15 |
| Third Resistance | 115.15 |
Wanbury Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 28,188 | 2,818,800 | 100 |
| Week | 87,097 | 8,709,740 | 100 |
| 1 Month | 54,720 | 5,471,995 | 100 |
| 6 Month | 47,637 | 4,763,711 | 100 |
Wanbury Result Highlights
Wanbury Synopsis
NSE-Medical-Generic Drugs
Wanbury is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 499.65 Cr. and Equity Capital is Rs. 32.71 Cr. for the Year ended 31/03/2023. Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455.| Market Cap | 385 |
| Sales | 549 |
| Shares in Float | 1.96 |
| No of funds | 4 |
| Yield |
| Book Value | 82.61 |
| U/D Vol ratio | 3.2 |
| LTDebt / Equity | |
| Alpha | 0.33 |
| Beta | 0.74 |
Wanbury
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | 39.8% | 39.84% | 39.84% | 39.84% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | ||||
| Financial Institutions/ Banks | ||||
| Individual Investors | 39.53% | 38.42% | 37.83% | 38.11% |
| Others | 20.67% | 21.74% | 22.33% | 22.05% |
Wanbury Management
| Name | Designation |
|---|---|
| Mr. K Chandran | Vice Chairman & Whole Time Dir |
| Mr. N K Puri | Ind. Non-Executive Director |
| Mr. S K Bhattacharya | Ind. Non-Executive Director |
| Ms. Pallavi P Shedge | Ind. Non-Executive Director |
| Mr. Binod Chandra Maharana | Ind. Non-Executive Director |
| Dr. Manisha Juvekar | Ind. Non-Executive Director |
Wanbury Forecast
Price Estimates
Wanbury Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-10-20 | Quarterly Results & Preferential issue | Inter-alia, to consider and evaluate proposals for raising of funds by way of a preferential issue/allotment and private placement to promoters/promoter group of the Company. |
| 2023-08-11 | Quarterly Results | |
| 2023-06-09 | Audited Results | (Revised) |
| 2023-02-14 | Quarterly Results | |
| 2022-11-28 | Quarterly Results | (Revised) |
Wanbury FAQs
What is Share Price of Wanbury ?
Wanbury share price is ₹117 As on 08 December, 2023 | 16:54
What is the Market Cap of Wanbury ?
The Market Cap of Wanbury is ₹384.5 Cr As on 08 December, 2023 | 16:54
What is the P/E ratio of Wanbury ?
The P/E ratio of Wanbury is 39.3 As on 08 December, 2023 | 16:54
What is the PB ratio of Wanbury ?
The PB ratio of Wanbury is -11.7 As on 08 December, 2023 | 16:54